Loading clinical trials...

Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT02405923

Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy

This is a multicenter, controlled, randomized, prospective, non-inferiority, double blind intervention trial to evaluate the children growth (at 6, 9 and 12 months) using a rice hydrolysed protein for...

Lead sponsor: Laboratorios Ordesa•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Infant Formula in Infants and Children With Cow's Milk Allergy

NCT06456541 · Cow's Milk Allergy

Not Yet RecruitingNA

Early Supplementation for Cow's Milk Allergy Prevention

NCT06652698 · Food Allergy, Cow's Milk Allergy

COMPLETEDNA

Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)

NCT02466035 · Cow's Milk Allergy

COMPLETED

Epigenetic Features of FoxP3 in Children With Cow's Milk Allergy

NCT02779881 · Cow's Milk Allergy

COMPLETED

Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy

NCT02379598 · Cow's Milk Allergy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 18, 2019Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment117

Start dateJul 2014

Last updatedJul 18, 2019

Condition

Cow's Milk Allergy

Locations shown

Hôpital Necker-Enfants Malades

Paris, Cedex 14

Hôpital Saint Vincent-de-Paul

Lille, Lille Cedex

Hospital Infantil Virgen del Rocío

Seville, Andalusia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 18, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions